Summary:
StemCell Technologies is committed to supporting stem cell and many other areas of life science research worldwide by providing enabling research tools that are innovative, timely and of consistently high quality. StemCell's specialized media and cell separation products are available for a wide range of research applications, and are complemented by a diverse array of cytokines, antibodies, tissue culture reagents, as well as services including contract assays, proficiency testing, and training.
Visit StemCell Technologies, Inc..

Description (Web site quote):
StemCell Technologies, Inc. is a privately owned, market-driven biotechnology company with offices in Canada, USA, UK, and France. StemCell provides highly specialized cell culture media and cell separation products that support and enable medical research in areas such as cancer, hematology, immunology, cell transplantation, gene therapy, and developmental biology. StemCell’s lead product, MethoCult™, is the industry standard media for hematopoietic progenitor assays. StemCell also offers training courses and coordinates a global proficiency testing program for hematopoietic progenitor assays, and provides contract assay services to the biotechnology and pharmaceutical industry.
Visit StemCell Technologies, Inc..